Literature DB >> 7698870

Remission of secondary Raynaud phenomenon using intra-arterial prostaglandin E1 infusion. A case report.

J Seemann1, J Scholz, M Sielwicz.   

Abstract

A man, aged 52 years, who had a secondary Raynaud phenomenon affecting the left hand and index finger had been treated unsuccessfully with intravenous prostaglandin E1 and amputation of the finger was proposed. He was given intra-arterial prostaglandin E1 for 10 days and amputation was not necessary. He recovered almost normal function of his hand and the improvement was maintained after 2 months.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7698870     DOI: 10.1007/bf00187085

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  8 in total

1.  The acute phase response in scleroderma. Differing responses to intravenous PGE1.

Authors:  E A Smith; M B Kahaleh; E C LeRoy
Journal:  Clin Exp Rheumatol       Date:  1986 Oct-Dec       Impact factor: 4.473

2.  Studies on pharmacokinetics, platelet function and fibrinolytic activity under various prostaglandin E1 infusion regimens.

Authors:  T Simmet; P Fitscha; B A Peskar; H Sinzinger; W Rogatti; V Tilsner
Journal:  Prog Clin Biol Res       Date:  1987

3.  Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis.

Authors:  M F Martin; J E Tooke
Journal:  Br Med J (Clin Res Ed)       Date:  1982-12-11

4.  Therapeutic efficacy of intravenously applied prostaglandin E1.

Authors:  P Scheffler; D de la Hamette; G Leipnitz
Journal:  Vasa Suppl       Date:  1989

5.  Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.

Authors:  M F Martin; P M Dowd; E F Ring; E D Cooke; P A Dieppe; J D Kirby
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

6.  Treatment of vasospastic disease with prostaglandin E1.

Authors:  P C Clifford; M F Martin; E J Sheddon; J D Kirby; R N Baird; P A Dieppe
Journal:  Br Med J       Date:  1980-10-18

Review 7.  Pathomechanisms of atherosclerosis beneficially affected by prostaglandin E1 (PGE1)--an update.

Authors:  H Sinzinger; I Virgolini; P Fitscha
Journal:  Vasa Suppl       Date:  1989

8.  Prostaglandin E1 in severe Raynaud's phenomenon.

Authors:  B J Pardy; M C Hoare; H H Eastcott; C C Miles; T N Needham; T Harbourne; B W Ellis
Journal:  Surgery       Date:  1982-12       Impact factor: 3.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.